Prostaglandin synthesis inhibitor improves hypotension during cardiopulmonary bypass

被引：0

作者：

Takewa, Y. ^{[1
]}

Seki, T. ^{[1
]}

Tatsumi, E. ^{[2
]}

Taenaka, Y. ^{[2
]}

Takano, H. ^{[2
]}

机构：

[1] Nara Prefectural Mimuro Hospital

[2] National Cardiovascular Center, Japan

来源：

ASAIO Journal | 2000年 / 46卷 / 02期

关键词：

Biosynthesis - Blood - Cardiovascular surgery - Drug dosage - Drug infusion - Hemodynamics - Urology;

D O I：

10.1097/00002480-200003000-00049

中图分类号：

学科分类号：

摘要：

In this study, an attempt was made to investigate whether prostaglandin (PG) synthesis inhibitor (PGSI) can improve hypotension during cardiopulmonary bypass (CPB). The mean systemic blood pressure (SBP), the blood base excess (BE), the urine output and the dose of metaraminol were estimated. Administration of PGSI during CPB improved hypotension and increased urine output without impairing peripheral circulation.

引用

共 50 条

[21] PROSTAGLANDIN INFLUENCE ON PULMONARY INTRAVASCULAR LEUKOCYTIC AGGREGATION DURING CARDIOPULMONARY BYPASS
BOLANOWSKI, PJP
BAUER, J
MACHIEDO, GW
NEVILLE, WE
SURGICAL FORUM, 1975, 26 : 216 - 217
[22] BRONCHOSPASM AND HYPOTENSION DURING CARDIOPULMONARY BYPASS AFTER PREOPERATIVE CIMETIDINE AND LABETALOL THERAPY
DURANT, PAC
JOUCKEN, K
BRITISH JOURNAL OF ANAESTHESIA, 1984, 56 (08) : 917 - 920
[23] Hypotension associated with clozapine after cardiopulmonary bypass
Donnelly, JG
MacLeod, AD
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1999, 13 (05) : 597 - 599
[24] Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis
Grayling, M
Deakin, CD
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (02): : 426 - 427
[25] Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass
Donahue, BS
Gailani, D
Mast, AE
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) : 1011 - 1016
[26] Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass
Pireaux, Valerie
Tassignon, Joel
Demoulin, Stephanie
Derochette, Sandrine
Borenstein, Nicolas
Ente, Angelique
Fiette, Laurence
Douxfils, Jonathan
Lancellotti, Patrizio
Guyaux, Michel
Godfroid, Edmond
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (17) : 2178 - 2189
[27] Thrombin activatable fibrinolysis inhibitor (TAFI) during cardiopulmonary bypass
Davidson, S. J.
Lindsey, D. A.
Tillyer, L.
Woodhams, B. J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 705 - 705
[28] EFFECTS AND ARTERIAL CONCENTRATION OF PROSTAGLANDIN-E1 DURING CARDIOPULMONARY BYPASS
OKUDA, M
FARUHASHI, K
KONISHI, K
MUNEYUKI, M
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1991, 8 (02) : 129 - 134
[29] Mechanical ventilation during cardiopulmonary bypass in neonates improves postoperative outcome
Rodriguez-Lima, Marta Macarena
Gonzalez-Calle, Antonio
Adsuar-Gomez, Alejandro
Sanchez-Martin, Maria Jose
Sepulveda Iturzaeta, Alvaro
Sanchez-Valderrabanos, Elia
Garcia-Hernandez, Juan Antonio
Murillo-Pozo, Maria Angeles
Ordonez-Fernandez, Antonio
Hosseinpour, Amir-Reza
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 61 (06) : 1283 - 1288
[30] SOME PROBLEMS OF PROSTAGLANDIN-E1 ADMINISTRATION DURING CARDIOPULMONARY BYPASS
ANZAI, T
JAPANESE JOURNAL OF THORACIC SURGERY, 1980, 33 (09): : 672 - 675

← 1 2 3 4 5 →